SCHEMBL10112937

SCHEMBL10112937

CC(C(=O)OC(C)(C)C)c1ccc(N2Cc3ccc(N)cc3C2=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
PKM P14618 3/20 0.51
TP53 P04637 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MEN1 O00255 1/20 0.51
LMNA P02545 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C19 P33261 1/20 0.51
KMT2A Q03164 1/20 0.51
PGR P06401 1/20 0.51
CYP3A4 P08684 1/20 0.51
GAA P10253 1/20 0.51
NFKB1 P19838 1/20 0.51
DRD1 P21728 1/20 0.51
HTT P42858 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
HTR1A P08908 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10113062 0.91 NPC1 (0.51) NPC1RAB9APKMTP53SMN1; SMN2
SCHEMBL10085852 0.89 NPC1 (0.51) NPC1RAB9APKMTP53SMN1; SMN2
SCHEMBL10132211 0.89 TP53 (0.47) NPC1RAB9APKMTP53SMN1; SMN2
SCHEMBL549670 0.88 NPC1 (0.50) NPC1RAB9APKMTP53SMN1; SMN2
SCHEMBL549162 0.88 TP53 (0.50) NPC1RAB9APKMTP53SMN1; SMN2
SCHEMBL10085867 0.87 SMN1; SMN2 (0.49) NPC1RAB9APKMTP53SMN1; SMN2
SCHEMBL10086514 0.86 NPC1 (0.48) NPC1RAB9APKMTP53SMN1; SMN2
SCHEMBL10085779 0.86 TP53 (0.48) NPC1RAB9APKMTP53SMN1; SMN2
SCHEMBL10085480 0.85 TP53 (0.47) NPC1RAB9APKMTP53SMN1; SMN2
SCHEMBL10085861 0.85 TP53 (0.47) NPC1RAB9APKMTP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110681-B2 Compounds for the treatment of spinal muscular atrophy and other uses THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2012-02-07 US disclosed
US-8110681-B2 Compounds for the treatment of spinal muscular atrophy and other uses THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2012-02-07 US disclosed